To assess the potential role of epigenetic control of CES1 promoter in neural cells as well, we used the neuroblastoma cell line SHSY5Y, which we treated with the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine (Aza). Here, CES1 is linked to neuroblastoma.